Pages that link to "Q7476596"
Jump to navigation
Jump to search
The following pages link to genital herpes (Q7476596):
Displayed 100 items.
- aciclovir (Q147101) (← links)
- valacyclovir (Q418594) (← links)
- famciclovir (Q420186) (← links)
- foscarnet (Q420387) (← links)
- herpes simplex (Q6473911) (← links)
- (Q12483860) (redirect page) (← links)
- (Q13025740) (redirect page) (← links)
- (Q15928979) (redirect page) (← links)
- (Q10295224) (redirect page) (← links)
- A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine (Q21089976) (← links)
- Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine (Q21562177) (← links)
- Reducing the risk of transmitting genital herpes: advances in understanding and therapy (Q22299200) (← links)
- Risk Factors for the Sexual Transmission of Genital Herpes (Q22305344) (← links)
- Determinants of disclosure of genital herpes to partners (Q22306474) (← links)
- Episodic therapy for recurrent genital herpes in non-immunocompromized adults (Q24187642) (← links)
- Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients (Q24194490) (← links)
- Interventions for men and women with their first episode of genital herpes (Q24201451) (← links)
- Antiviral therapy for genital herpes for prevention of HIV transmission (Q24234315) (← links)
- Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients (Q24236379) (← links)
- Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection (Q24242853) (← links)
- The effects of antiviral therapy of genital herpes in HIV-infected individuals (Q24245937) (← links)
- Third trimester antiviral therapy for preventing recurrent genital herpes at delivery (Q24246421) (← links)
- Tzanck smear in diagnosing genital herpes (Q24530172) (← links)
- Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis (Q24642232) (← links)
- Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions (Q24656625) (← links)
- Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia (Q24670332) (← links)
- Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection (Q24671668) (← links)
- The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches (Q24801371) (← links)
- Prevention of genital herpes in a guinea pig model using a glycoprotein D-specific single chain antibody as a microbicide (Q24803342) (← links)
- Optimal management of genital herpes: current perspectives (Q26746041) (← links)
- Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies (Q26861777) (← links)
- The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes (Q28262699) (← links)
- Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type (Q28288314) (← links)
- Virologic characteristics of subclinical and symptomatic genital herpes infections (Q28295661) (← links)
- Current thinking on genital herpes (Q28303928) (← links)
- Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial (Q28345700) (← links)
- Efficacy of the acyclic guanosine analog buciclovir [(R)-9-(3,4-dihydroxybutyl)guanine] in experimental genital herpes (Q28360403) (← links)
- Efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigs (Q28366907) (← links)
- Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes (Q28369457) (← links)
- (Q28919674) (redirect page) (← links)
- Genital Herpes: Insights into Sexually Transmitted Infectious Disease (Q30235026) (← links)
- School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents. (Q30241622) (← links)
- Stress and genital herpes recurrences in women (Q30305501) (← links)
- Vaccine prevents genital herpes in subgroup of women. (Q30310514) (← links)
- Orofacial herpes and other localizations (genital herpes and neonatal herpes excluded) (Q30331192) (← links)
- Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review (Q30402908) (← links)
- Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes (Q30496837) (← links)
- Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection (Q30576590) (← links)
- CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. (Q30657379) (← links)
- Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials (Q30991218) (← links)
- Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials (Q31028568) (← links)
- Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes (Q33248961) (← links)
- Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa (Q33336603) (← links)
- Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial (Q33451849) (← links)
- Improving the management of genital herpes (Q33536654) (← links)
- New concepts in understanding genital herpes (Q33582145) (← links)
- Genital herpes: an increasing problem? (Q33582624) (← links)
- Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study (Q33582991) (← links)
- Acyclovir in first attacks of genital herpes and prevention of recurrences (Q33583052) (← links)
- Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes (Q33583056) (← links)
- A rapid and sensitive culture test for the laboratory diagnosis of genital herpes in women. (Q33583086) (← links)
- Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences (Q33583092) (← links)
- Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study (Q33583249) (← links)
- Epidemiology of genital herpes - recent advances. (Q33598315) (← links)
- Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy (Q33604358) (← links)
- Obstetrics and gynecology-important advances in clinical medicine: genital herpes and vaginal delivery. (Q33605657) (← links)
- A possible psychoneuroimmunologic basis for recurrent genital herpes simplex (Q33605766) (← links)
- Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States (Q33614235) (← links)
- New developments in the epidemiology, natural history and management of genital herpes (Q33638308) (← links)
- Genital herpes simplex virus infection and gonorrhoea. Association and analogies (Q33654014) (← links)
- False positive FTA-ABS results in patients with genital herpes (Q33654851) (← links)
- Diagnosis of genital herpes simplex virus infection in the clinical laboratory (Q33655295) (← links)
- A trial of adenine arabinoside in genital herpes (Q33655822) (← links)
- Recurrent genital herpes among women: symptomatic v. asymptomatic viral shedding (Q33655980) (← links)
- Treatment with acyclovir of genital herpes simplex virus infection complicated by eczema herpeticum. (Q33660163) (← links)
- A psychoeducational program increased knowledge and decreased sexual risk behaviors in young adults with genital herpes (Q33727485) (← links)
- A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections (Q33748184) (← links)
- Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data (Q33750736) (← links)
- Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse (Q33750747) (← links)
- Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs (Q33758576) (← links)
- Safety of famciclovir in patients with herpes zoster and genital herpes (Q33761829) (← links)
- Characteristics associated with genital herpes testing among young adults: assessing factors from two national data sets. (Q33780584) (← links)
- The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. (Q33783025) (← links)
- Improving the care of patients with genital herpes (Q33801850) (← links)
- Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue (Q33835473) (← links)
- The biopsychosocial burden of genital herpes: evidence-based and other approaches to care. (Q33835478) (← links)
- Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation (Q33835479) (← links)
- Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity (Q33843902) (← links)
- Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes (Q33856050) (← links)
- Recurrent genital herpes and quality of life in France (Q33873007) (← links)
- RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. (Q33883922) (← links)
- Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes (Q33885705) (← links)
- Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety (Q33889911) (← links)
- A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). (Q33899638) (← links)
- Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections (Q33914361) (← links)
- Public Health Strategies to Prevent Genital Herpes: Where Do We Stand? (Q33926487) (← links)
- Asymptomatic shedding and subsequent transmission of genital herpes simplex virus (Q33931152) (← links)
- Recurrent genital herpes: clinical and virological features in men and women (Q33931593) (← links)
- Psychosocial implications of recurrent genital herpes simplex virus infection (Q33931849) (← links)
- Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex (Q33931987) (← links)